ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,251,343 | +23.2% | 555,483 | +14.2% | 0.00% | +100.0% |
| Q2 2023 | $26,183,235 | +43.2% | 486,406 | +5.7% | 0.00% | 0.0% |
| Q1 2023 | $18,278,032 | -49.3% | 460,172 | -48.6% | 0.00% | 0.0% |
| Q4 2022 | $36,045,034 | +147.3% | 895,974 | +97.6% | 0.00% | 0.0% |
| Q3 2022 | $14,575,000 | +5.5% | 453,480 | -2.6% | 0.00% | 0.0% |
| Q2 2022 | $13,818,000 | +15.0% | 465,724 | +8.9% | 0.00% | 0.0% |
| Q1 2022 | $12,019,000 | -40.4% | 427,582 | -2.3% | 0.00% | 0.0% |
| Q4 2021 | $20,164,000 | +49.5% | 437,580 | +6.5% | 0.00% | 0.0% |
| Q3 2021 | $13,490,000 | -3.8% | 411,020 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $14,021,000 | -1.8% | 400,035 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $14,275,000 | +56.1% | 394,992 | +25.4% | 0.00% | 0.0% |
| Q4 2020 | $9,145,000 | +7.2% | 314,909 | +4.2% | 0.00% | 0.0% |
| Q3 2020 | $8,529,000 | -13.6% | 302,337 | -1.0% | 0.00% | 0.0% |
| Q2 2020 | $9,872,000 | -25.5% | 305,272 | -6.2% | 0.00% | 0.0% |
| Q1 2020 | $13,255,000 | -30.6% | 325,353 | +5.0% | 0.00% | 0.0% |
| Q4 2019 | $19,109,000 | -13.4% | 309,863 | +2.3% | 0.00% | -50.0% |
| Q3 2019 | $22,071,000 | -7.0% | 302,834 | +4.9% | 0.00% | 0.0% |
| Q2 2019 | $23,736,000 | +26.9% | 288,765 | +8.9% | 0.00% | +100.0% |
| Q1 2019 | $18,701,000 | +72.1% | 265,112 | +9.8% | 0.00% | 0.0% |
| Q4 2018 | $10,868,000 | -29.0% | 241,398 | -10.8% | 0.00% | 0.0% |
| Q3 2018 | $15,298,000 | -17.1% | 270,474 | -2.2% | 0.00% | -50.0% |
| Q2 2018 | $18,463,000 | +12.2% | 276,476 | -2.2% | 0.00% | +100.0% |
| Q1 2018 | $16,459,000 | -10.2% | 282,654 | -0.6% | 0.00% | 0.0% |
| Q4 2017 | $18,320,000 | +28.6% | 284,240 | +4.7% | 0.00% | 0.0% |
| Q3 2017 | $14,251,000 | +2.9% | 271,593 | -8.2% | 0.00% | 0.0% |
| Q2 2017 | $13,849,000 | -8.0% | 295,951 | -2.6% | 0.00% | 0.0% |
| Q1 2017 | $15,046,000 | -20.8% | 303,995 | -3.0% | 0.00% | -50.0% |
| Q4 2016 | $19,000,000 | -15.5% | 313,477 | -7.5% | 0.00% | 0.0% |
| Q3 2016 | $22,491,000 | +38.2% | 338,943 | +16.3% | 0.00% | 0.0% |
| Q2 2016 | $16,272,000 | +169.6% | 291,439 | +62.5% | 0.00% | +100.0% |
| Q1 2016 | $6,036,000 | -65.5% | 179,363 | -53.7% | 0.00% | -50.0% |
| Q4 2015 | $17,492,000 | -30.3% | 387,558 | -39.0% | 0.00% | -33.3% |
| Q3 2015 | $25,095,000 | -42.9% | 635,023 | -10.4% | 0.00% | -40.0% |
| Q2 2015 | $43,961,000 | -2.3% | 708,487 | -1.5% | 0.01% | 0.0% |
| Q1 2015 | $44,995,000 | +91.8% | 719,246 | +72.9% | 0.01% | +150.0% |
| Q4 2014 | $23,465,000 | +967.1% | 416,094 | +434.7% | 0.00% | – |
| Q3 2014 | $2,199,000 | -11.2% | 77,816 | +8.3% | 0.00% | – |
| Q2 2014 | $2,477,000 | +15381.2% | 71,876 | +450.2% | 0.00% | – |
| Q4 2013 | $16,000 | +23.1% | 13,063 | +0.2% | 0.00% | – |
| Q2 2013 | $13,000 | – | 13,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |